September, 29 2025 Monday 23:58 Hrs
Ifin-logo
  • SENSEX :   80,364.94

  • Top commodity trading and broking companies in India-61.52( -0.08%) 29-Sep-2025
Login for
FundBoss
Trade Online
Open Account
top-arrow-market
Sensex 80364.94 -61.52  (-0.08) 29-Sep-2025
Previous Day Close
80426.46
Today's High/Low
High Low
  •  
  •  
80851.38 80248.84

Board Meetings

Today's Board meetings
Forthcoming Board meetings
Company Name companyname-top-arrow Date companyname-top-arrow Purpose companyname-top-arrow
AGI Greenpac 30-Sep-25 Agi Greenpac Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2025 inter alia to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI Listing Regulations we would like to inform you that a meeting of the Board of Directors of AGI Greenpac Limited (Company) is scheduled to be held on Tuesday 30th September 2025 inter alia to consider and evaluate a proposal for raising of funds by way of issuance of securities i.e. equity shares or any instrument or security including fully / partially convertible debentures or non-convertible debentures or warrants entitling the warrant holder(s) to apply for equity shares global depository receipts american depository receipts foreign currency convertible bonds or any other eligible securities in one or more tranches through the permissible modes including but not limited to private placement preferential issue qualified institutions placement or such other methods or combinations thereof as may be considered appropriate and decided by the Board subject to approval of the shareholders and other .
Jyoti Structures 30-Sep-25 Inter alia, to consider and approve:- 1. To take on record and deliberate upon the Letter of Intent (LOI) received from Telexcell Trade PTE LTD, Singapore, for a proposed acquisition of up to 25% equity stake in Welcure Drugs & Pharmaceuticals Ltd. at an indicative price of Rs.20 per share (a substantial premium over the prevailing market price). 2. To initiate the process of comprehensive due diligence in respect of the proposed transaction, including legal, financial, and regulatory aspects. 3. To consider authorizing the Company's representatives to negotiate and finalize the terms of definitive agreements, in alignment with Welcure's long-term growth strategy and compliance with applicable regulatory frameworks. 4. To explore enabling mechanisms for shareholder approval through postal ballot / general meeting, in line with SEBI, RBI, FEMA, and stock exchange requirements. 5. To deliberate on future strategic growth opportunities in global pharmaceutical and chemical exports, leveraging Telexcell's global trade network.
Cyber Media Ind 30-Sep-25 Cyber Media India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2025 inter alia to consider and approve Merger and amalgamation with the Company of Cyber Media Research & Services Limited subsidiary of the Company.
Sampann Utpadan 30-Sep-25 Sampann Utpadan India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2025 inter alia to consider and approve Pursuant to Regulation 29 (1) (d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and other applicable Regulations if any a meeting of the Board of Directors of Sampann Utpadan India Limited is scheduled to be held on Tuesday 30th September 2025 to consider and approve the allotment of Equity Shares having face value Rs. 10 each on partial conversion of Convertible Warrants out of 10500000 (One Crore Five Lakh) convertible warrants allotted on 17.02.2025.
Alstone Textiles 30-Sep-25 Alstone Textiles (India) Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2025 inter alia to consider and approve To consider and approve the proposal for raising of funds by way of issue of equity shares of Rs.1/- per share at par or any other eligible securities through one or more of the permissible modes including but not limited to qualified institutions placement rights issue preferential issue further public offer etc. subject to requisite approvals under the applicable laws including approval of shareholders of the Company as may be required in this regard.
Likhami Consult. 30-Sep-25 Likhami Consulting Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2025 inter alia to consider and approve A meeting of the Board of Director of the Company will be held on Tuesday 30th September 2025 at 3:00 P.M. at its Registered office of the Company to inter-alia consider / approve the following business/ agenda as under : 1.To take the note of letter of resignation tendered by Mrs. Heena Banga Sharma (DIN: 10193235) Non-Executive Independent Director of the Company. 2.To take the note of letter of resignation tendered by Non-executive Director Mr. Sanjoy Kumar Singh (DIN: 07684128) of the Company. 3.To take the note of letter of resignation tendered by Mr. Babu Lal Jain (DIN: 02467622) Managing Director & CEO of the Company. 4.To Consider and appointment of Managing Director & CEO. 5.To Consider and appointment of Non-Executive Director. 6.To Consider and appointment of Non-Executive Independent Director 7.To discuss any other matters with the permission of the Chairman. Likhami Consulting Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/09/2025 ,inter alia, to consider and approve A meeting of the Board of Director of the Company will be held on Tuesday, 30th September, 2025 at 3:00 P.M., at its Registered office of the Company to inter-alia consider / approve the following business/ agenda as under : 1.To take the note of letter of resignation tendered by Mrs. Heena Banga Sharma, (DIN: 10193235) Non-Executive Independent Director of the Company. 2.To take the note of letter of resignation tendered by Non-executive Director Mr. Sanjoy Kumar Singh (DIN: 07684128) of the Company. 3.To take the note of letter of resignation tendered by Mr. Babu Lal Jain (DIN: 02467622) Managing Director & CEO of the Company. 4.To Consider and appointment of Managing Director & CEO. 5.To Consider and appointment of Non-Executive Director. 6.To Consider and appointment of Non-Executive Independent Director 7.To discuss any other matters with the permission of the Chairman (As Per BSE Announcement Dated On : 20.09.2025)
Top
Attention Investor:
Prevent unauthorised transactions in your account Update your mobile numbers/email IDs with your stock brokers/Depository Participant.     KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, ,Mutual ).    No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.